Skip to content

Trauma and Emergency Medicine

Anticoagulation Management and Reversal

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (opens new window)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Source‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Indexed‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (opens new window)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (opens new window)

Levi M, Eerenberg E, Kamphuisen PW.

Source‎: J Thromb Haemost 2011;9(9):1705-12.

Indexed‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (opens new window)

Emergency reversal of warfarin anticoagulation. (opens new window)

Lin Y, Callum J.

Source‎: CMAJ 2010;182(18):2004.

Indexed‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (opens new window)

Management of anticoagulation agents in trauma patients. (opens new window)

McCoy CC, Lawson JH, Shapiro ML.

Source‎: Clin Lab Med 2014;34(3):563-74.

Indexed‎: PubMed 25168942

DOI‎: 10.1016/j.cll.2014.06.013

https://www.ncbi.nlm.nih.gov/pubmed/25168942 (opens new window)

Idarucizumab for dabigatran reversal - full cohort analysis. (opens new window)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Source‎: N Engl J Med 2017;377(5):431-41.

Indexed‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (opens new window)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (opens new window)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Source‎: Anesth Analg 2011;113(4):703-10.

Indexed‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (opens new window)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (opens new window)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Source‎: World Neurosurg 2014;81(1):110-5.

Indexed‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (opens new window)

TRAUMA AND EMERGENCY MEDICINE
Anticoagulation Management and Reversal
English
Anticoagulation Management and Reversal
https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

Hospital Liaison Committee (HLC)

Contact local representatives who provide free assistance to clinicians treating Jehovah’s Witnesses.

Contact

Medical Information Packets

Subjects include: Clinical strategies for managing hemorrhage and anemia without blood transfusion, the religious and ethical position of Jehovah’s Witnesses on medical therapy, and the services Witnesses offer to the medical community through their worldwide network of Hospital Liaison Committees.

View Downloads

Videos

Treatment options as well as medical and ethical considerations for clinicians who treat Jehovah’s Witnesses.

View Videos